The term LOC388282 Inhibitors refers to a class of chemical compounds specifically designed to modulate the activity of LOC388282, a molecular target whose detailed functions and biological roles may be subject to ongoing research. LOC388282 itself likely plays a crucial role in various cellular processes, and inhibitors within this class aim to interfere with its normal function. These inhibitors are meticulously crafted through medicinal chemistry approaches, involving the synthesis and optimization of chemical structures to achieve a high level of selectivity and potency in inhibiting LOC388282.
The chemical structures of LOC388282 Inhibitors are characterized by specific molecular features that facilitate binding to the target site on LOC388282, disrupting its normal biochemical activities. The development of these inhibitors often involves a combination of computational modeling, structure-activity relationship studies, and iterative synthesis to fine-tune their properties. Researchers focus on understanding the three-dimensional structure of LOC388282 and the binding interactions between the inhibitor and the target to enhance the efficacy of the inhibitors. The detailed investigation of LOC388282 Inhibitors is pivotal not only for understanding the biological functions of LOC388282 but also for potential applications in various research fields.
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $279.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits topoisomerase II, which could lead to reduced transcription and potentially decrease the expression of genes like LOC388282. |